MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH increased its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 54.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 24,075 shares of the company's stock after acquiring an additional 8,510 shares during the quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH's holdings in Colgate-Palmolive were worth $2,499,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in CL. Scarborough Advisors LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $116,000. Fisher Asset Management LLC raised its holdings in Colgate-Palmolive by 1,010.7% in the fourth quarter. Fisher Asset Management LLC now owns 3,210 shares of the company's stock worth $256,000 after purchasing an additional 2,921 shares during the period. MONECO Advisors LLC boosted its position in shares of Colgate-Palmolive by 18.7% during the fourth quarter. MONECO Advisors LLC now owns 5,615 shares of the company's stock worth $448,000 after purchasing an additional 885 shares in the last quarter. Leo Wealth LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at $494,000. Finally, Quadrature Capital Ltd bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $4,046,000. Institutional investors own 80.41% of the company's stock.
Shares of Colgate-Palmolive stock opened at $100.77 on Tuesday. The company's 50 day moving average price is $103.55 and its two-hundred day moving average price is $97.33. The firm has a market capitalization of $82.68 billion, a P/E ratio of 31.89, a P/E/G ratio of 3.54 and a beta of 0.40. Colgate-Palmolive has a fifty-two week low of $71.07 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70.
Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The company had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. During the same quarter last year, the business posted $0.77 EPS. Colgate-Palmolive's revenue for the quarter was up 4.9% on a year-over-year basis. On average, equities analysts forecast that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 1.98%. Colgate-Palmolive's dividend payout ratio is presently 63.29%.
In other news, Director Martina Hundmejean sold 2,313 shares of the firm's stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares of the company's stock, valued at approximately $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the firm's stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the transaction, the insider now owns 13,942 shares in the company, valued at approximately $1,439,929.76. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Martina Hundmejean sold 2,313 shares of the company's stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,490 shares of company stock valued at $4,486,063 in the last ninety days. 0.34% of the stock is currently owned by insiders.
Several equities analysts recently issued reports on CL shares. Citigroup boosted their price objective on Colgate-Palmolive from $103.00 to $112.00 and gave the company a "buy" rating in a research report on Wednesday, July 10th. JPMorgan Chase & Co. increased their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a research report on Friday. Stifel Nicolaus boosted their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a "buy" rating in a research report on Monday, July 22nd. Hsbc Global Res cut Colgate-Palmolive from a "strong-buy" rating to a "hold" rating in a report on Friday, July 26th. Finally, Redburn Atlantic upgraded Colgate-Palmolive to a "hold" rating in a report on Thursday, August 1st. One analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $106.00.
Read Our Latest Stock Analysis on Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.